Pharmacy experts discuss pharmacists' expanding role as vaccinatorsA DSN webinar featured three panelists who highlighted pharmacists' expanded role as vaccinators amid the COVID-19 pandemic. Walgreens resumes immunizations with new safety measuresWalgreens is resuming immunization services ahead of flu season, with safety measures that adhere to new CDC guidelines. Merck acquires Themis Merck’s acquisition of Themis is expected to accelerate the development of a measles vector-based SARS-CoV-2 vaccine candidate. Sanofi, GSK collaborate to develop COVID-19 vaccine Sanofi and GSK aim to complete the development required for availability of a COVID-19 vaccine by the second half of 2021. Merck gets FDA green light for Ervebo Merck's Ervebo is indicated for the prevention of disease caused by Zaire ebolavirus in individuals 18 years old and older. First Previous 34 35 36